Mario Castellanos

Mario Castellone

Innovene, Inc

2016-2017

Affiliations

State University of New York

Technologies

Therapeutic

Indication

Clinical Research

Infectious Disease

Oncology

Women's health

Executive Summary

View/Download

Innovene has designed a new class of medications from safe plant-derived components; TriCurin will target the unmet medical need of treating patients with oncogenic human papillomavirus infections.

Newsletter Signup

Corporate Supporters

Community Service Providers